Tranche 1 warrant proceeds
Company: Core Scientific
The claim, verbatim
The company expects approximately $650 million in cash proceeds from the exercise of Tranche 1 warrants around their January 2027 expiration.
Source (primary)
What Core Scientific (CORZ) Said on Its Q3 Earnings Call - Yahoo Finance (-, news_article)
View cached copy (2026-11-06)Live source ↗Archive.org ↗
Quote: “the company expects approximately $650 million in cash proceeds from the exercise of Tranche 1 warrants around their January 2027 expiration”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms What Core Scientific (CORZ) Said on Its Q3 Earnings Call - Yahoo Finance
Quote: “the company expects approximately $650 million in cash proceeds from the exercise of Tranche 1 warrants around their January 2027 expiration”
confirms [Core Scientific Q3 2026 Earnings Call] Colocation Revenue Jumps 60% to $215M, Adjusted EBITDA Triples to $134M as CoreWeave Capacity Hits 485 MW - BigGo Finance
Quote: “Core Scientific also expects approximately $650 million in cash proceeds from the exercise of its Tranche 1 warrants around their January 2027 expiration.”